Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
1987 • 2,769 citations
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
1985 • 2,616 citations
Interleukin 2
1984 • 497 citations
Drug-induced pancreatitis: A critical review
1980 • 401 citations
Clinical effects and toxicity of interleukin-2 in patients with cancer
1986 • 359 citations
New Approaches to the Immunotherapy of Cancer Using Interleukin-2
1988 • 202 citations
Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
1988 • 197 citations
Acute Pancreatitis
1985 • 55 citations
Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.
1987 • 45 citations
Colonic perforation: An unusual complication of therapy with high-dose lnterleukin-2
1988 • 35 citations
Acute Pancreatitis
1988 • 14 citations